Synapse - Advanced Practice Providers

Search Within

Advanced Practice Providers

Results (161)

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial

Journal Article

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
The Lancet Haematology (2021)

Fulltext@MSK | Save

Identification of a TP53 deletion in an undifferentiated embryonal sarcoma of the liver provides clinically relevant longitudinal detection of circulating tumor DNA

Journal Article

Kothari, P.; Sauerhaft, T.; Bouvier, N.; Rodriguez-Sanchez, M. I.; Shia, J.; Price, A.; Morjaria, S.; Gerstle, J. T.; Shukla, N. N.; Ortiz, M. V.
JCO Precision Oncology (2021)

Fulltext@MSK | Save

Debio1347, an oral FGFR inhibitor: Results from a single-center study in pediatric patients with recurrent or refractory FGFR-altered gliomas

Journal Article

Sait, S. F.; Gilheeney, S. W.; Bale, T. A.; Haque, S.; Dinkin, M. J.; Vitolano, S.; Rosenblum, M. K.; Ibanez, K.; Prince, D. E.; Spatz, K. H.; more...
JCO Precision Oncology (2021)

Fulltext@MSK | Save

Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups

Meeting Abstract

Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
European Urology (2021)

Fulltext@MSK | Save

Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy

Journal Article

Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
Blood (2021)

Fulltext@MSK | Save

Debio1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric glioma

Meeting Abstract

Sait, S. F.; Gilheeney, S.; Bale, T.; Rosenblum, M.; Haque, S.; Ibanez, K.; Dinkin, M.; Vitolano, S.; Dunkel, I.; Karajannis, M.
Neuro-Oncology (2021)

Fulltext@MSK | Save

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in adolescent and young adult (AYA) brain tumor patients

Meeting Abstract

Miller, A.; Szalontay, L.; Bouvier, N.; Ahmed, H.; Hill, K.; Rafailov, J.; Lee, A.; Rodriguez-Sanchez, I.; Yildirim, O.; Patel, A.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial

Journal Article

Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
JAMA Oncology (2021)

Fulltext@MSK | Save

The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results

Meeting Abstract

Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
Hematological Oncology (2021)

Fulltext@MSK | Save

Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors

Journal Article

Funt, S. A.; McHugh, D. J.; Tsai, S.; Knezevic, A.; O'Donnell, D.; Patil, S.; Silber, D.; Bromberg, M.; Carousso, M.; Reuter, V. E.; more...
The Oncologist (2021)

Fulltext@MSK | Save